DE3853224D1 - Produktion von Proteinen in aktiver Form. - Google Patents

Produktion von Proteinen in aktiver Form.

Info

Publication number
DE3853224D1
DE3853224D1 DE3853224T DE3853224T DE3853224D1 DE 3853224 D1 DE3853224 D1 DE 3853224D1 DE 3853224 T DE3853224 T DE 3853224T DE 3853224 T DE3853224 T DE 3853224T DE 3853224 D1 DE3853224 D1 DE 3853224D1
Authority
DE
Germany
Prior art keywords
protein
cationic exchange
proteins
active form
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853224T
Other languages
English (en)
Other versions
DE3853224T2 (de
Inventor
Malcolm Roy Brandon
Joseph John Patroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantinco Nv Willensted Curacao An
Original Assignee
Southern Cross Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Cross Biotech Pty Ltd filed Critical Southern Cross Biotech Pty Ltd
Application granted granted Critical
Publication of DE3853224D1 publication Critical patent/DE3853224D1/de
Publication of DE3853224T2 publication Critical patent/DE3853224T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3853224T 1987-04-21 1988-04-21 Produktion von Proteinen in aktiver Form. Expired - Fee Related DE3853224T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI150887 1987-04-21

Publications (2)

Publication Number Publication Date
DE3853224D1 true DE3853224D1 (de) 1995-04-13
DE3853224T2 DE3853224T2 (de) 1995-06-29

Family

ID=3772123

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853224T Expired - Fee Related DE3853224T2 (de) 1987-04-21 1988-04-21 Produktion von Proteinen in aktiver Form.

Country Status (11)

Country Link
US (1) US5008377A (de)
EP (1) EP0288280B1 (de)
JP (1) JPS646292A (de)
KR (1) KR880012753A (de)
AT (1) ATE119543T1 (de)
CA (1) CA1305285C (de)
DE (1) DE3853224T2 (de)
ES (1) ES2068827T3 (de)
MY (1) MY103362A (de)
NZ (1) NZ224295A (de)
ZA (1) ZA882774B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms
EP0529086B1 (de) * 1991-02-26 1999-05-19 Ajinomoto Co., Inc. Verfahren zur reinigung von menschlichem bcdf
US6031075A (en) * 1996-02-05 2000-02-29 Children's Hospital Medical Center Mature alveolar SP-B and a process for producing the same
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
CN1264575C (zh) 1998-08-06 2006-07-19 山景药品公司 聚乙二醇或聚环氧乙烷－尿酸氧化酶结合物及其应用
KR20080009111A (ko) 2005-04-11 2008-01-24 새비언트 파마수티컬즈 인크. 유레이트 옥시다아제의 변이형 및 이의 용도
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
MX2007012548A (es) * 2005-04-11 2008-03-11 Savient Pharmaceuticals Inc Formas variantes de urato oxidasa y uso de las mismas.
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
PL2013225T3 (pl) * 2006-04-12 2015-06-30 Crealta Pharmaceuticals Llc Oczyszczanie białek z zastosowaniem kationowego środka powierzchniowo czynnego
PL398781A1 (pl) 2009-06-25 2012-11-19 Savient Pharmaceuticals, Inc. Sposoby i zestawy do prognozowania ryzyka wystapienia reakcji na wlew oraz zaniku odpowiedzi której posrednicza przeciwciala poprzez monitorowanie kwasu moczowego w surowicy podczas terapii z zastosowaniem pegylowanej urykazy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
US4766224A (en) * 1985-08-19 1988-08-23 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms

Also Published As

Publication number Publication date
JPS646292A (en) 1989-01-10
DE3853224T2 (de) 1995-06-29
MY103362A (en) 1993-06-30
ES2068827T3 (es) 1995-05-01
ATE119543T1 (de) 1995-03-15
EP0288280B1 (de) 1995-03-08
NZ224295A (en) 1990-06-26
ZA882774B (en) 1988-10-20
KR880012753A (ko) 1988-11-29
EP0288280A2 (de) 1988-10-26
EP0288280A3 (en) 1990-04-11
US5008377A (en) 1991-04-16
CA1305285C (en) 1992-07-14

Similar Documents

Publication Publication Date Title
DE3382837T2 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
DK247084A (da) 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer, fremgangsmaader til deres fremstilling samt antibakterielle midler indeholdende disse
ATE73138T1 (de) Reinigung und aktivierung von proteinen aus unloeslichen einschlusskoerpern.
EP0215625A3 (en) Protein recovery
DE3853224D1 (de) Produktion von Proteinen in aktiver Form.
DE3884356D1 (de) Verfahren zur Herstellung von Fremdprotein in Hefe, Rekombinant DNS, Transformant.
WO1994024160A3 (en) Erythropoietin muteins with enhanced activity
DK0383234T3 (da) Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling
IT8220921A0 (it) Soluzione per dialisi contenente glucosio, aminoacidi e insulina.
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
AU4764385A (en) Method for silver staining proteins and nucleic acids
EP0239311A3 (de) Wechselseitige Trennung von Proteinen
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DE3580631D1 (de) Methode zur trennung von blutbestandteilen.
DE3788170T2 (de) Methode zur Reinigung und Isolierung von zwei ionischen Formen von Somatomedin.
DE209855T1 (de) Aminosaeure-derivate, nuetzlich zur deaktivation von enzymen.
GR3003950T3 (de)
DE3677851D1 (de) Verfahren zur steigerung der produktion von rekombinantem protein in hefearten der gattung saccharomyces.
ATE93546T1 (de) Ergaenzungstestverfahren von proteine bindenden enzymen.
ES295383U (es) Mesa desmontable para ordenadores
BR8205912A (pt) Processo de separacao das proteinas contidas nas turfas hidricas, (sapropelitos).

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NANTINCO, NV, WILLENSTED, CURACAO, AN

8339 Ceased/non-payment of the annual fee